2023
DOI: 10.1177/15353702231151987
|View full text |Cite
|
Sign up to set email alerts
|

Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma

Abstract: CD5+ diffuse large B-cell lymphoma (DLBCL), as a significant heterogeneity category of DLBCL, is reflected in both the molecular biological and genetic levels, which in turn induces ever-changing clinical manifestations, and what mediates tumor survival mechanisms are still unclear. This study aimed to predict the potential hub genes in CD5+ DLBCL. A total of 622 patients with DLBCL diagnosed between 2005 and 2019 were included. High expression of CD5 was correlated with IPI, LDH, and Ann Arbor stage, patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…After screening of differentially expressed genes and construction of PPI network, MCODE provides an e cient way to narrow down the number of functional module clusters containing potential key hub genes [9]. This method has been used in liver cancer [11], lymphoma [12] and glioma [13] and other studies. Four main clusters of proteins were outlined in hPASCs and each carried out unique molecular functions.…”
Section: Discussionmentioning
confidence: 99%
“…After screening of differentially expressed genes and construction of PPI network, MCODE provides an e cient way to narrow down the number of functional module clusters containing potential key hub genes [9]. This method has been used in liver cancer [11], lymphoma [12] and glioma [13] and other studies. Four main clusters of proteins were outlined in hPASCs and each carried out unique molecular functions.…”
Section: Discussionmentioning
confidence: 99%